During the past decade, Seoul National University Hospital, Department of Internal Medicine conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 25 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University Hospital, Department of Internal Medicine" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Pfizer" with 14 trials sponsored, "Seoul National University Hospital" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Yonsei University" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University Hospital, Department of Internal Medicine" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University Hospital, Department of Internal Medicine" are "Breast Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Gastric Cancer" (2 trials), "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC" (1 trials) and "Adenoid Cystic Carcinoma" (1 trials). Many other conditions were trialed in "Seoul National University Hospital, Department of Internal Medicine" in a lesser frequency.

Most popular intervention types in "Seoul National University Hospital, Department of Internal Medicine" are "Drug" (37 trials), "Other" (5 trials), "Combination Product" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Docetaxel" (6 trials), "Pertuzumab" (6 trials), "Trastuzumab" (5 trials) and "5-Fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University Hospital, Department of Internal Medicine" are 36 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Seoul National University Hospital, Department of Internal Medicine". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Seoul National University Hospital, Department of Internal Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University Hospital, Department of Internal Medicine, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".